Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders - Archive ouverte HAL Access content directly
Journal Articles Revue Neurologique Year : 2018

Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders

Not file

Dates and versions

hal-03538511 , version 1 (21-01-2022)

Identifiers

Cite

J. Ciron, B. Audoin, B. Bourre, David Brassat, R. Marignier, et al.. Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders. Revue Neurologique, 2018, 174 (4), pp.255-264. ⟨10.1016/j.neurol.2017.11.005⟩. ⟨hal-03538511⟩
24 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More